Julie Kronen
Women's Health · Silver Spring, MDNPI 1295429603
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $370 of the $460 with a category attached, or 80.4%. 10 manufacturers reported payments, led by Astellas Pharma US Inc at 52.1% of the total. 2025 is the largest year on record at $290, 3.5 times the $83 reported in 2023.
Across 18 payments — averaging $25.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$239
- Amgen$38
- Exeltis, USA Inc.$37
- Mayne Pharma Commercial LLC$27
- Shield Therapeutics Inc$25
- Lilly USA, LLC$22
- plus $71 from 4 others
What the payments were for
- Food & beverage$37080%
- Education$9020%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 7 | $239 |
| Amgen | 2 | $38 |
| Exeltis, USA Inc. | 2 | $37 |
| Mayne Pharma Commercial LLC | 1 | $27 |
| Shield Therapeutics Inc | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Pfizer | 1 | $16 |
| Coopersurgical, Inc. | 1 | $16 |
How this compares
$460 in reported general payments places this provider in the 55th percentile of 95 women's health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 11 | $157 |
Paid to pharmacies, not to this prescriber.
Other women's health in Silver Spring
- Brooke EllingerSilver Spring$2K
- Joan LefkofSilver Spring$2K
- Hannah TulkoffSilver Spring$1K
- Gina KrumlSilver Spring$914
- Alexandra CunninghamSilver Spring$746
- Erin McAleerSilver Spring$710
- Rebecca BurkeSilver Spring$338
- Jasmine WhitcombBaltimore$15K
- Ariel PaskinBaltimore$5K
- Crystal SmithGambrills$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.